Published by Genomax LLC, Wyoming · How we fund testing · Editorial standards · Methodology

Editorial Standards

Editorial disclosure. This site is operated by Genomax LLC, which also operates the GenoMAX² supplement brand. Outbound product links may earn a commission. No supplement-brand sponsorship influences our ratings. See Editorial Standards and How We Review.

By NSW Editorial Team · Reviewed by the NSW Editorial Board · Updated

Editorial disclosure: site operated by Genomax LLC (dba GenoMAX²); may earn commission on linked products.

NutraScienceWatch operates under a public editorial standards policy. Every article is written, reviewed, and updated per the protocol below.

Sourcing standards

Primary sources only

We cite from:

We do NOT cite:

Citation format

Every dose, mechanism, bioavailability figure, and clinical outcome carries an inline PubMed PMID or equivalent identifier:

"Berberine activates AMP-activated protein kinase (PMID 18397984)."

Readers can verify every claim by clicking the PMID link.

Methodology page

Every article links back to How We Review which describes the article-level review checklist.

Editorial independence

Sponsorship transparency

NutraScienceWatch is operated by Genomax LLC, a dietary supplement company doing business as GenoMAX². This relationship is disclosed:

Link policy

When an article references an ingredient we sell, we may include exactly ONE contextual link to the relevant Genomax LLC product page. This link:

We do not link to any other commercial brand. We do not accept paid placements from any third party.

Decline-to-cover policy

If an ingredient or product category has insufficient peer-reviewed evidence, we either decline to publish OR explicitly state the evidence gap. We do not publish to support sales of products with weak evidence.

Content review cycle

Quarterly review

Every article is reviewed once per quarter:

Reader-facing changelog

When an article undergoes a substantive revision, a changelog entry is published at the top of the article noting:

Correction policy

Errors are corrected within 48 hours of detection. Significant corrections are noted at the top of the article in red text for 14 days, then moved to the changelog.

What we do NOT do

Editorial team

Articles are written and reviewed by the NSW Editorial Team, an internal editorial group operated by Genomax LLC. Individual author bylines are not disclosed at this time because:

See Editorial Team for team-level credentials and review process.

Compliance

This site complies with:

Contact for editorial standards questions

[email protected]

These statements have not been evaluated by the Food and Drug Administration. This site is for educational purposes and is not a substitute for medical advice.